Insomnia Archives

SleepApneaDisorder/[Press Release]/-Dr. Markus Schmidt will review common sleep disorders and cardiovascular consequences of sleep apnea on Saturday, August 21st at 1:00 p.m. at the Health & Fitness Expo held at the Columbus Convention Center. The lecture is free and opened to the public attending the event.  

“Many residents in Central Ohio suffer from a sleep problem or disorder that affects not only their quality of life, but also their daytime performance and can have profound consequences on their overall mental and physical health,” says Dr. Markus Schmidt, medical director at the Ohio Sleep Medicine Institute. “Sleep is a vital element for our well-being, and addressing underlying conditions that contribute to insomnia, snoring, sleep apnea, restless nights or other sleep disturbances can completely change one’s life,” he adds. Read the rest of this entry

Valley Oximetry Sleep Disorders Center (Valley Sleep Center) announced the opening of their fourth sleep clinic in Scottsdale, Arizona.

The new clinic is located at 9767 N 91st Street Suite B104, Scottsdale, AZ 85258, and will be accepting new patients on September 1st, 2010. Valley Sleep Center recently opened their third location in Glendale this past April. They also have facilities located in Mesa and Phoenix.

Valley Sleep Center is one of the largest independent sleep diagnostics centers in the valley with the facilities to diagnose and treat a variety of sleep-related issues such as insomnia, sleep walking, snoring, and more. Read the rest of this entry

Ambulatory BP studies indicate that even small increases in BP, particularly nighttime BP levels, are associated with significant increases in cardiovascular morbidity and mortality.

Accordingly, sleep-related diseases that induce increases in BP would be anticipated to substantially affect cardiovascular risk. Both sleep deprivation and insomnia have been linked to increases in incidence and prevalence of hypertension.

Likewise, sleep disruption attributable to restless legs syndrome increases the likelihood of having hypertension. Read the rest of this entry

The technique, used while patients are awake, is called scripting or dream mastery and is part of imagery rehearsal therapy, which Dr. Krakow helped develop. The therapy is being used to treat a growing number of nightmare sufferers. In recent years, nightmares have increasingly been viewed as a distinct disorder, and researchers have produced a growing body of empirical evidence that this kind of cognitive therapy can help reduce their frequency and intensity, or even eliminate them.

“In your mind, with thinking and picturing, take a few minutes, close your eyes, and I want you to change the dream any way you wish,” said Dr. Krakow, founder of the P.T.S.D. Sleep Clinic at the Maimonides Sleep Arts and Sciences center here and a leading researcher of nightmares.

“We call that a new dream,” Dr. Krakow told Ms. Gurule. “The bad dream is over there” — he pointed across the room — “and we’re not dealing with that. We’re dealing with the new dream.” Read the rest of this entry

If one does not get sleep or can’t stay asleep or waking up many times in the middle of the night, the person can count him to be suffering from sleep deprivation which has solution.

According to Carolyn Schur, founder of Associated Sleep services in Saskatoon, Sask a fatigue management specialist and a sleep teacher; it all begins with proper diagnosis.

She added that most people suffering from sleep disorders are insomniacs and two thirds of her patients can also be termed that. Read the rest of this entry

Cherry juice could hold the key to a good night’s sleep, say scientists.

Volunteers who drank a glass of unsweetened cherry juice in the morning and evening enjoyed more shut-eye than when they drank the same amount of other juices, a study found.

Curing insomnia has become one of the biggest health challenges of the modern age.

About one in four adults suffer from it and a fifth regularly get fewer than five hours’ sleep a night. Read the rest of this entry

Silenor Promotion as Insomnia Treatment

[Press Release]- SAN DIEGO – Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that it has established a commercial team to promote Silenor(R) (doxepin) for the treatment of insomnia characterized by difficulties with sleep maintenance. Read the rest of this entry

Related Posts with Thumbnails